JPMorgan Chase & Co. 13D and 13G filings for Coherus BioSciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-12-07 2:45 pm Sale | 2023-11-30 | 13G | Coherus BioSciences, Inc. CHRS | JPMORGAN CHASE & CO JPM | 124,796 0.100% | -5,538,974 (-97.80%) | Filing |
| 2023-01-18 1:30 pm Sale | 2022-12-30 | 13G | Coherus BioSciences, Inc. CHRS | JPMORGAN CHASE & CO JPM | 5,663,770 7.200% | -691,417 (-10.88%) | Filing |
| 2022-01-07 3:41 pm Purchase | 2021-12-31 | 13G | Coherus BioSciences, Inc. CHRS | JPMORGAN CHASE & CO JPM | 6,355,187 8.200% | 1,392,505 (+28.06%) | Filing |
| 2021-01-08 11:43 am Purchase | 2020-12-31 | 13G | Coherus BioSciences, Inc. CHRS | JPMORGAN CHASE & CO JPM | 4,962,682 6.800% | 1,494,928 (+43.11%) | Filing |